Organometallic Iridium(III) Cyclopentadienyl Anticancer Complexes Containing C,N-Chelating Ligands
- 5 August 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Organometallics
- Vol. 30 (17), 4702-4710
- https://doi.org/10.1021/om2005468
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Physicochemical Studies and Anticancer Potency of Ruthenium η6-p-Cymene Complexes Containing Antibacterial QuinolonesOrganometallics, 2011
- Organometallic Half-Sandwich Iridium Anticancer ComplexesJournal of Medicinal Chemistry, 2011
- Organometallic Anticancer CompoundsJournal of Medicinal Chemistry, 2010
- Trapping Unstable Benzoquinone Analogues by Coordination to a [(η5-C5Me5)Ir] Fragment and the Anticancer Activity of the Resulting ComplexesAngewandte Chemie-International Edition, 2010
- Current applications and future potential for bioinorganic chemistry in the development of anticancer drugsDrug Discovery Today, 2009
- Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activityJBIC Journal of Biological Inorganic Chemistry, 2009
- Controlling platinum, ruthenium, and osmium reactivity for anticancer drug designAdvances in Inorganic Chemistry, 2009
- Osmium(II) and Ruthenium(II) Arene Maltolato Complexes: Rapid Hydrolysis and Nucleobase BindingChemistry – A European Journal, 2007
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- The electronic structure of the purine-pyrimidine pairs of DNABiochimica et Biophysica Acta, 1959